M&T Bank
TARS icon

M&T Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

M&T Bank’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$202K Buy
+2,560
New +$178K ﹤0.01% 1641
2026
Q2 		– Sell
-3,035
Closed -$213K – 1837
2026
Q1 		$213K Sell
3,035
-80
-3% -$5.59K ﹤0.01% 1544
2025
Q4 		$255K Sell
3,115
-580
-16% -$43.3K ﹤0.01% 1475
2025
Q3 		$219K Buy
+3,695
New +$182K ﹤0.01% 1348

Other funds holding TARS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

M&T Bank's TARS Position: Q3 2026 in Review

M&T Bank opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2026: 2,560 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #1641 among its holdings. This is a return to the name: M&T Bank previously reported a position in TARS as recently as Q1 2026.

M&T Bank first reported a position in TARS in Q3 2025 and has held it in 4 quarters since. The position peaked at $255K in Q4 2025. 113 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • M&T Bank held 2,560 shares of Tarsus Pharmaceuticals worth $202K as of Q3 2026.
  • Tarsus Pharmaceuticals was a new M&T Bank position in Q3 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1641 holding.
  • M&T Bank first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • M&T Bank's Tarsus Pharmaceuticals position peaked at $255K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.